Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
HivTobacco Use
Interventions
BEHAVIORAL

EX+

All participants, regardless of study arm, will be offered: BecomeAnEX, an online tobacco treatment with support community PLUS Positively Smoke Free on the Web (an intervention targeting people with HIV who smoke) integrated into the BecomeAnEX site.

DRUG

Varenicline

All participants, regardless of study arm, will be offered: A 12-week course of varenicline dosed according to product label.

BEHAVIORAL

HR

Participants allocated to the EX+/HR arm will be offered: 30-minute video urging smokers who cannot or will not quit to cut down on cigarettes, and also to control their risk for lung cancer and cardio or cerebrovascular disease by undergoing low-dose CT screening for lung cancer (for those meeting prespecified criteria), and referral to Cardiometabolic Clinic (for those meeting prespecified criteria).

BEHAVIORAL

TAU

Participants allocated to the EX+/TAU arm will be offered: Medical treatment as usual from their regular providers after completing Stage 1 of the study

Trial Locations (1)

10467

RECRUITING

Montefiore Medical Center, The Bronx

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Westat

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Truth Initiative

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Montefiore Medical Center

OTHER